Cargando…
Chemical Synthesis, Pharmacokinetic Properties and Biological Effects of JM-00266, a Putative Non-Brain Penetrant Cannabinoid Receptor 1 Inverse Agonist
Targeting cannabinoid 1 receptors (CB1R) with peripherally restricted antagonists (or inverse agonists) shows promise to improve metabolic disorders associated with obesity. In this context, we designed and synthetized JM-00266, a new CB1R blocker with limited blood–brain barrier (BBB) permeability....
Autores principales: | Muller, Tania, Demizieux, Laurent, Troy-Fioramonti, Stéphanie, Buch, Chloé, Leemput, Julia, Belloir, Christine, Pais de Barros, Jean-Paul, Jourdan, Tony, Passilly-Degrace, Patricia, Fioramonti, Xavier, Le Bon, Anne-Marie, Vergès, Bruno, Robert, Jean-Michel, Degrace, Pascal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8949893/ https://www.ncbi.nlm.nih.gov/pubmed/35328343 http://dx.doi.org/10.3390/ijms23062923 |
Ejemplares similares
-
Endocannabinoids Produced by White Adipose Tissue Modulate Lipolysis in Lean but Not in Obese Rodent and Human
por: Buch, Chloé, et al.
Publicado: (2021) -
Therapeutic potential of a novel peripherally restricted CB1R inverse agonist on the progression of diabetic nephropathy
por: Jacquot, Laetitia, et al.
Publicado: (2023) -
Orosensory Detection of Dietary Fatty Acids Is Altered in CB(1)R(−/−) Mice
por: Brissard, Léa, et al.
Publicado: (2018) -
CB1 Antagonism Exerts Specific Molecular Effects on Visceral and Subcutaneous Fat and Reverses Liver Steatosis in Diet-Induced Obese Mice
por: Jourdan, Tony, et al.
Publicado: (2010) -
Liraglutide reduces plasma dihydroceramide levels in patients with type 2 diabetes
por: Denimal, Damien, et al.
Publicado: (2023)